Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
about
Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lungOverview of the biology of type I interferonsThe autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunityThe role for protein tyrosine phosphatase non-receptor type 22 in regulating intestinal homeostasisImmunomodulatory functions of type I interferonsOntogeny of intestinal epithelial innate immune responsesMultiple roles of toll-like receptor 4 in colorectal cancerIndoleamine 2,3 dioxygenase in intestinal diseaseHuman β-Defensin 3 [corrected] Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic AcidActivation of anti-hepatitis C virus responses via Toll-like receptor 7.Osteopontin expression by CD103- dendritic cells drives intestinal inflammationTwist mediates suppression of inflammation by type I IFNs and AxlTLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in miceGeneration of mouse small intestinal epithelial cell lines that allow the analysis of specific innate immune functionsThe p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury.Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice.Isolation of bacteria from mouse caecal samples and description of Bacteroides sartorii sp. nov.The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms.Fetal exposure to maternal inflammation does not affect postnatal development of genetically-driven ileitis and colitisTLR8-mediated activation of human monocytes inhibits TL1A expression.Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans.STAT2 contributes to promotion of colorectal and skin carcinogenesis.Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitisConstitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosisThe DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense.NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathwayLocalized delivery of interferon-β by Lactobacillus exacerbates experimental colitisHigh frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis.Microbes in gastrointestinal health and diseaseAberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis.MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism.Toll-like receptors in inflammatory bowel diseases: a decade later.Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.Murine gut microbiota is defined by host genetics and modulates variation of metabolic traitsToll-like receptor 9 gene mutations and polymorphisms in Japanese ulcerative colitis patients.
P2860
Q21131368-7710F4EB-D4BF-4522-AFD5-F3A14D5537A5Q21195364-93759CD4-E408-4FF6-A4D9-672E6BB9CA8FQ24310219-525548B3-2BB0-4B44-BBAF-C41209C2BEA6Q26741130-FB21ED71-58EE-4BDF-80D2-C4E0D0ED0F5DQ26823904-8A236D63-D0C5-423C-9656-527FDC060E1EQ27004090-A9D56701-E31B-4C96-A74F-38F76E154839Q27008380-DE7E0294-BC04-4942-95A0-B310974AC6B9Q27025063-1BBCC841-310D-48DD-94AE-3D4C047A1179Q27310039-6EFFBE96-D1E3-41E7-91B0-DDF34B28EBD3Q27473105-821590BA-1489-4B3F-8DD7-BCDC2BCDA3FBQ28307824-39B41025-B2C0-40B2-8FDF-18CA0CF3DFADQ28509359-E9A06B84-58D0-4BD1-90AE-5D559C745E3EQ28513789-FA5B7BED-1CA3-475C-9F8F-E38CBA7C4CE6Q28535135-D3AFBB3A-817B-4403-BC80-1C2317B6E4DAQ30577895-41490A7E-E9C5-495B-A2E0-4DF3B7B896EBQ33381642-0E1F0E1D-5868-49F2-B172-C736274A57CFQ33406281-064230AD-C320-4AB7-BC71-E4A8EBC27C34Q33412853-6D40DDB6-9FB2-4868-9C22-A3A8E3E654DCQ33549739-1357040E-5256-4492-A833-B64810CDF2B2Q33594436-51CA1E36-9445-4168-BB46-D37C7715ED53Q33607300-118E37AF-56A2-4E5E-88C5-03988FA491CFQ33645831-64A6BA88-C62A-4BEA-B880-4084B38863ACQ33731098-F219C1BB-4BAF-41CC-9B29-B9513705E233Q33746984-83497995-32D8-44FE-A89D-D190D6268067Q33776485-49C56BFA-99E4-4A69-B408-2AD0A4036AECQ33788157-8C6ABB50-6F03-44EC-8CA7-33BD0CE4AE2DQ33802845-0E1808A5-9439-4740-A70E-F2FE7C61D2E0Q33814705-6DC37BE4-1B06-4985-8053-E40D4F51785BQ33815718-67EF1C38-2215-4CC4-B10A-445D07737074Q33834191-6BE8EF9A-A8D4-4DAC-BA24-B7C69DA5B694Q33898849-0520C468-218C-4E31-8885-FD001545ED95Q33943525-0F90A6B8-23C4-444B-BA20-4C6F1F777C44Q33962421-59B96306-25E9-4351-A4A9-B3E848279D2BQ34044424-A04AD67C-4D53-4471-B3FF-265E1C209676Q34110714-067B5747-ABD9-4FFA-83B0-77BE42C2FAC2Q34134813-AD10F511-5AE3-41F9-BFB0-F5B5C6DE0E87Q34154099-F53B0F2A-A9A6-45CB-B4EA-92006435200CQ34164176-3BB26794-DE1D-4629-A17E-149B1640F51AQ34314273-F636D603-D818-473C-A697-7E69CE6385C1Q34406452-06FBC5D5-9B8E-4F97-BE87-0DB9E31E94D2
P2860
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
@ast
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
@en
type
label
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
@ast
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
@en
prefLabel
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
@ast
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
@en
P2093
P2860
P356
P1476
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.
@en
P2093
Daniel Rachmilewitz
Jongdae Lee
Kyoko Katakura
Lars Eckmann
P2860
P304
P356
10.1172/JCI22996
P407
P577
2005-03-01T00:00:00Z